2026 Q2 Portfolio Activity
In 2026 Q2, Frazier Life Sciences Management, L.P. maintained a portfolio of 44 distinct positions. The most significant new addition was ACHIEVE LIFE SCIENCE INC, now representing 1.08% of the total fund value. They heavily accumulated shares in PARABILIS MEDICINES INC, increasing the position by 354.6%. The fund also reduced its exposure to BRIDGEBIO PHARMA INC by 55.1%.
Position History
hover any row below to update
Loading…
Frazier Life Sciences Management, L.P.
Seattle, WA
Life Sciences Venture Capital / Growth Equity
AUM $4,592M
Total Positions
44
Quarter
2026 Q2
Top Holding
MIRM (19.6%)
Top 10 Concentration
73.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-44 of 44
Frazier Life Sciences Management, L.P. Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 19.58% | 18.25% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
7,679,684 | $899,060,606 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 13.35% | 13.96% |
#2
Prev: #2
|
7.5 |
—
|
1,145,128 | 6.8% |
P
S
|
18,088,902 | $613,032,889 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ERAS
ERASCA INC
|
Healthcare | 9.96% | 10.27% |
#3
Prev: #3
|
5.5 |
—
|
300,000 | 1.2% |
P
S
|
24,975,188 | $457,545,444 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 8.00% | 5.11% |
#4
2
Prev: #6
|
4.7 |
—
|
no change | no change |
P
S
|
6,652,013 | $367,191,118 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 5.64% | 5.99% |
#5
Prev: #5
|
3.8 |
—
|
no change | no change |
P
S
|
9,874,511 | $258,909,678 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 4.04% | 3.05% |
#6
4
Prev: #10
|
2.1 |
—
|
-100 | -0.0% |
P
S
|
9,939,447 | $185,370,687 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 3.90% | 3.20% |
#7
2
Prev: #9
|
2.6 |
—
|
no change | no change |
P
S
|
481,307 | $178,887,373 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 3.27% | 3.51% |
#8
Prev: #8
|
3.3 |
—
|
465,641 | 10.2% |
P
S
|
5,032,915 | $150,182,184 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PHAT
PHATHOM PHARMAC...
|
Healthcare | 2.95% | 3.56% |
#9
2
Prev: #7
|
2.2 |
—
|
no change | no change |
P
S
|
12,466,489 | $135,261,406 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 2.94% | 2.83% |
#10
1
Prev: #11
|
2.2 |
—
|
no change | no change |
P
S
|
882,400 | $134,848,368 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 2.51% | 6.59% |
#11
7
Prev: #4
|
1.0 |
—
|
-1,900,000 | -55.1% |
P
S
|
1,548,139 | $115,305,393 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 2.16% | 2.23% |
#12
1
Prev: #13
|
1.9 |
—
|
no change | no change |
P
S
|
1,354,852 | $99,093,875 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 2.15% | 1.97% |
#13
1
Prev: #14
|
1.9 |
—
|
no change | no change |
P
S
|
1,159,879 | $98,810,092 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.53% | 1.47% |
#14
2
Prev: #16
|
1.6 |
—
|
no change | no change |
P
S
|
3,153,082 | $70,029,951 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 1.31% | 0.78% |
#15
10
Prev: #25
|
3.5 |
—
|
91,822 | 68.9% |
P
S
|
225,155 | $60,053,342 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SVRA
SAVARA INC
|
Healthcare | 1.30% | 1.37% |
#16
1
Prev: #17
|
1.5 |
—
|
no change | no change |
P
S
|
9,720,852 | $59,880,448 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
PARABILIS MEDIC...
|
|
Unknown | 1.14% | — |
#17
Prev: #—
|
4.0 |
—
|
1,920,805 | — |
NEW
|
1,920,805 | $52,572,433 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 1.10% | 0.88% |
#18
5
Prev: #23
|
2.9 |
—
|
2,000,000 | 39.2% |
P
S
|
7,100,000 | $50,410,000 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACHV
ACHIEVE LIFE SC...
|
Healthcare | 1.08% | — |
#19
Prev: #—
|
3.9 |
—
|
7,614,836 | — |
NEW
|
7,614,836 | $49,724,879 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 1.02% | 1.17% |
#20
1
Prev: #19
|
1.4 |
—
|
no change | no change |
P
S
|
2,543,939 | $46,833,917 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALLO
ALLOGENE THERAP...
|
Healthcare | 1.02% | 0.24% |
#21
14
Prev: #35
|
3.4 |
—
|
18,650,000 | 491.2% |
P
S
|
22,446,668 | $46,689,069 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 1.00% | 1.32% |
#22
4
Prev: #18
|
1.4 |
—
|
no change | no change |
P
S
|
728,644 | $45,860,853 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 0.87% | 0.98% |
#23
2
Prev: #21
|
1.3 |
—
|
no change | no change |
P
S
|
4,009,240 | $40,092,400 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 0.80% | 0.64% |
#24
3
Prev: #27
|
1.3 |
—
|
no change | no change |
P
S
|
700,647 | $36,710,400 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 0.79% | 0.82% |
#25
1
Prev: #24
|
1.3 |
—
|
no change | no change |
P
S
|
1,438,198 | $36,386,409 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZLAB
ZAI LAB LTD
|
Healthcare | 0.79% | 0.92% |
#26
4
Prev: #22
|
1.3 |
—
|
no change | no change |
P
S
|
1,902,320 | $36,144,080 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MNKD
MANNKIND CORP
|
Healthcare | 0.61% | 0.37% |
#27
4
Prev: #31
|
2.2 |
—
|
700,000 | 11.9% |
P
S
|
6,600,000 | $28,116,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DSGN
DESIGN THERAPEU...
|
Healthcare | 0.57% | — |
#28
Prev: #—
|
3.7 |
—
|
1,809,854 | — |
NEW
|
1,809,854 | $26,188,587 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACRS
ACLARIS THERAPE...
|
Healthcare | 0.57% | 0.48% |
#29
1
Prev: #28
|
1.2 |
—
|
no change | no change |
P
S
|
4,925,374 | $26,055,228 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
STTK
SHATTUCK LABS I...
|
Healthcare | 0.57% | — |
#30
Prev: #—
|
3.7 |
—
|
3,750,000 | — |
NEW
|
3,750,000 | $26,025,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
KAILERA THERAPE...
|
|
Unknown | 0.53% | — |
#31
Prev: #—
|
3.7 |
—
|
1,100,000 | — |
NEW
|
1,100,000 | $24,233,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 0.53% | 0.42% |
#32
3
Prev: #29
|
1.2 |
—
|
no change | no change |
P
S
|
1,000,000 | $24,200,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LXEO
LEXEO THERAPEUT...
|
Healthcare | 0.49% | 0.65% |
#33
7
Prev: #26
|
2.2 |
—
|
400,000 | 9.0% |
P
S
|
4,824,725 | $22,459,095 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 0.41% | — |
#34
Prev: #—
|
3.7 |
—
|
1,015,693 | — |
NEW
|
1,015,693 | $19,003,616 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EOLS
EVOLUS INC
|
Healthcare | 0.40% | 0.28% |
#35
2
Prev: #33
|
1.2 |
—
|
no change | no change |
P
S
|
2,630,665 | $18,256,815 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 0.34% | 0.38% |
#36
6
Prev: #30
|
1.1 |
—
|
no change | no change |
P
S
|
484,782 | $15,391,829 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VALN
VALNEVA SE
|
Healthcare | 0.26% | 0.37% |
#37
5
Prev: #32
|
1.1 |
—
|
no change | no change |
P
S
|
2,291,666 | $11,985,413 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NAMSW
NEWAMSTERDAM PH...
|
Unknown | 0.23% | 0.26% |
#38
4
Prev: #34
|
1.1 |
—
|
no change | no change |
P
S
|
500,333 | $10,692,116 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AUTL
AUTOLUS THERAPE...
|
Healthcare | 0.15% | 0.16% |
#39
3
Prev: #36
|
1.1 |
—
|
no change | no change |
P
S
|
4,447,910 | $7,116,656 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
XILIO THERAPEUT...
|
|
Unknown | 0.09% | 0.09% |
#40
2
Prev: #38
|
1.0 |
—
|
no change | no change |
P
S
|
422,505 | $4,047,598 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
IBIO
IBIO INC
|
Healthcare | 0.07% | 0.10% |
#41
4
Prev: #37
|
1.0 |
—
|
no change | no change |
P
S
|
1,953,467 | $3,418,567 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 0.00% | 1.09% |
Sold All 😨
(Was: #20) |
0.0 |
—
|
-1,256,080 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 0.00% | 1.69% |
Sold All 😨
(Was: #15) |
0.0 |
—
|
-675,686 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 0.00% | 2.57% |
Sold All 😨
(Was: #12) |
0.0 |
—
|
-4,961,108 | -100.0% |
CLOSED
|
— | $— | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-44 of 44 holdings